TherapeuticsMD (TXMD) Non Operating Income (2010 - 2026)

TherapeuticsMD (TXMD) has reported Non Operating Income for 17 consecutive years, with $980000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Income fell 20.97% year-over-year to $980000.0; the trailing twelve-month figure through Jun 2026 stood at $3.7 million (up 16.96% YoY), and the FY2025 full-year result was $3.7 million, down 0.85% from the prior year.
• Non Operating Income rose to $980000.0 in Q2 2026 per TXMD's latest filing, from $826000.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $1.7 million in Q2 2024 and bottomed at -$22.8 million in Q1 2022.
• Historically, Non Operating Income has averaged -$733944.4 across 5 years, with a median of $462000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Non Operating Income tumbled 125.55% in 2022, then jumped 2898.28% in 2024.
• Over 5 years, Non Operating Income stood at $11000.0 in 2022, then surged by 145.45% to $27000.0 in 2023, then surged by 2622.22% to $735000.0 in 2024, then jumped by 32.24% to $972000.0 in 2025, then gained by 0.82% to $980000.0 in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $980000.0, $826000.0, and $972000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.